Richard L. Raymond

Array ( [id] => 1262885 [patent_doc_number] => RE038332 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Selected soluble esters of hydroxyl-containing indolocarbazoles' [patent_app_type] => E1 [patent_app_number] => 09/811725 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11260 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 831 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038332.pdf [firstpage_image] =>[orig_patent_app_number] => 09811725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017005 [patent_doc_number] => 20020103192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Inhibitors of histone deacetylase' [patent_app_type] => new [patent_app_number] => 09/808389 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26963 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103192.pdf [firstpage_image] =>[orig_patent_app_number] => 09808389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009454 [patent_doc_number] => 06900216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents' [patent_app_type] => utility [patent_app_number] => 10/221459 [patent_app_country] => US [patent_app_date] => 2001-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43675 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 382 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900216.pdf [firstpage_image] =>[orig_patent_app_number] => 10221459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1237385 [patent_doc_number] => 06685617 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Inhibitors of 41 mediated cell adhesion' [patent_app_type] => B1 [patent_app_number] => 09/720088 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/685/06685617.pdf [firstpage_image] =>[orig_patent_app_number] => 09720088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707051 [patent_doc_number] => 20030153785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Method for preserving quaternary ammonium salt' [patent_app_type] => new [patent_app_number] => 09/959698 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21566 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153785.pdf [firstpage_image] =>[orig_patent_app_number] => 09959698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1289383 [patent_doc_number] => 06632808 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Inhibitors of amyloid formation' [patent_app_type] => B1 [patent_app_number] => 09/762725 [patent_app_country] => US [patent_app_date] => 2001-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 12015 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632808.pdf [firstpage_image] =>[orig_patent_app_number] => 09762725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908321 [patent_doc_number] => 20010011088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => '1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a HIV protease inhibitor' [patent_app_type] => new [patent_app_number] => 09/795932 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7581 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011088.pdf [firstpage_image] =>[orig_patent_app_number] => 09795932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189092 [patent_doc_number] => 06734184 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)' [patent_app_type] => B1 [patent_app_number] => 09/763709 [patent_app_country] => US [patent_app_date] => 2001-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20962 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734184.pdf [firstpage_image] =>[orig_patent_app_number] => 09763709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440697 [patent_doc_number] => 06495720 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Method for preparing alkoxyamines from nitroxides' [patent_app_type] => B1 [patent_app_number] => 09/719042 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4103 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 594 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495720.pdf [firstpage_image] =>[orig_patent_app_number] => 09719042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1398994 [patent_doc_number] => 06531478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-11 [patent_title] => 'Amino pyrazole derivatives useful for the treatment of obesity and other disorders' [patent_app_type] => B2 [patent_app_number] => 09/791203 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13608 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 513 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531478.pdf [firstpage_image] =>[orig_patent_app_number] => 09791203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462814 [patent_doc_number] => 06350743 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Cytotoxic pyridoacridine alkaloids' [patent_app_type] => B1 [patent_app_number] => 09/554181 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1706 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350743.pdf [firstpage_image] =>[orig_patent_app_number] => 09554181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189091 [patent_doc_number] => 06734183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-11 [patent_title] => 'Compounds' [patent_app_type] => B2 [patent_app_number] => 09/788687 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15055 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734183.pdf [firstpage_image] =>[orig_patent_app_number] => 09788687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892358 [patent_doc_number] => 20010018520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith' [patent_app_type] => new [patent_app_number] => 09/789473 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32458 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018520.pdf [firstpage_image] =>[orig_patent_app_number] => 09789473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475652 [patent_doc_number] => 06388072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-14 [patent_title] => 'Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith' [patent_app_type] => B2 [patent_app_number] => 09/789464 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31592 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 908 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388072.pdf [firstpage_image] =>[orig_patent_app_number] => 09789464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721560 [patent_doc_number] => 20030055250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Pteridine compounds for the treatment of psoriasis' [patent_app_type] => new [patent_app_number] => 10/204814 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15987 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055250.pdf [firstpage_image] =>[orig_patent_app_number] => 10204814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009481 [patent_doc_number] => 06900243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Phenylheteroalkylamine derivatives' [patent_app_type] => utility [patent_app_number] => 10/204845 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13446 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900243.pdf [firstpage_image] =>[orig_patent_app_number] => 10204845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774697 [patent_doc_number] => 20030018035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Substituted arylpyrazines' [patent_app_type] => new [patent_app_number] => 09/788315 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38510 [patent_no_of_claims] => 162 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018035.pdf [firstpage_image] =>[orig_patent_app_number] => 09788315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575174 [patent_doc_number] => 06469003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Pyridazinone derivatives' [patent_app_type] => B1 [patent_app_number] => 09/762877 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14768 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1645 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469003.pdf [firstpage_image] =>[orig_patent_app_number] => 09762877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876877 [patent_doc_number] => 20010007030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'Synthesis of 11-aryl-5,6,-dihydro-11H-dibenz [b,e] azepines' [patent_app_type] => new-utility [patent_app_number] => 09/777528 [patent_app_country] => US [patent_app_date] => 2001-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4084 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007030.pdf [firstpage_image] =>[orig_patent_app_number] => 09777528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474985 [patent_doc_number] => 06387895 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Vitronectin receptor antagonists, their preparation and their use' [patent_app_type] => B1 [patent_app_number] => 09/777011 [patent_app_country] => US [patent_app_date] => 2001-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29121 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387895.pdf [firstpage_image] =>[orig_patent_app_number] => 09777011 [rel_patent_id] =>[rel_patent_doc_number] =>)